Nona Biosciences
Nona Biosciences is a biotechnology company offering integrated solutions for antibody discovery and development. Leveraging our proprietary Harbour Mice® platforms, which generate fully human H2L2 and heavy chain-only antibodies (HCAbs), our approach supports a wide range of therapeutic formats. The H2L2 Open Access Platform enables rapid entry into discovery, while Modalities-on-Demand™ provides tailored support for ADCs as well as next-generation modalities including bispecifics, CAR-T, and TCEs. With capabilities spanning immunization, screening, engineering, and IND-enabling services, Nona empowers partners to move efficiently from idea to IND with flexibility and confidence.
